Literature DB >> 25363218

Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.

Nera Agabiti1, Maria Assunta Porretta, Lisa Bauleo, Angelo Coppola, Gianluigi Sergiacomi, Armando Fusco, Francesco Cavalli, Maria Cristina Zappa, Rossana Vignarola, Stefano Carlone, Gianpiero Facchini, Salvatore Mariotta, Paolo Palange, Salvatore Valente, Giovanna Pasciuto, Gabriella Pezzuto, Augusto Orlandi, Danilo Fusco, Marina Davoli, Cesare Saltini, Ermanno Puxeddu.   

Abstract

BACKGROUND: Studies of Idiopathic Pulmonary Fibrosis (IPF) epidemiology show regional variations of incidence and prevalence; no epidemiological studies have been carried out in Italy.
OBJECTIVE: To determine incidence and prevalence rates of IPF in the population of a large Italian region.
METHODS: in this cross-sectional study study data were collected on all patients of 18 years of age and older admitted as primary or secondary idiopathic fibrosing alveolitis (ICD9-CM 516.3) to Lazio hospitals, from 1/1/2005 to 31/12/2009, using regional hospital discharge, population and cause of death databases. Reporting accuracy was assessed on a random sample of hospital charts carrying the ICD9-CM 516.3, 516.8, 516.9 and 515 codes, by reviewing radiology and pathology findings to define cases as IPF "confident", "possible" or "inconsistent".
RESULTS: Annual prevalence and incidence of IPF were estimated at 25.6 per 100,000 and 7.5 per 100,000 using the ICD9-CM code 516.3 without chart audit while they were estimated at 31.6 per 100,000 and at 9,3 per 100,000 for the IPF "confident" definition after hospital chart audit.
CONCLUSION: The data provide a first estimate of IPF incidence in Italy and indicate that incidence and prevalence in southern European regions may be similar to those observed in northern Europe and North America.

Entities:  

Mesh:

Year:  2014        PMID: 25363218

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  18 in total

1.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.

Authors:  Boris Duchemann; Isabella Annesi-Maesano; Camille Jacobe de Naurois; Shreosi Sanyal; Pierre-Yves Brillet; Michel Brauner; Marianne Kambouchner; Sophie Huynh; Jean Marc Naccache; Raphael Borie; Jacques Piquet; Arsène Mekinian; Jerôme Virally; Yurdagul Uzunhan; Jacques Cadranel; Bruno Crestani; Olivier Fain; Francois Lhote; Robin Dhote; Nathalie Saidenberg-Kermanac'h; Paul-André Rosental; Dominique Valeyre; Hilario Nunes
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  High-resolution computed tomography and magnetic resonance imaging protocols in the diagnosis of fibrotic interstitial lung disease: overview for "non-radiologists".

Authors:  Gianluigi Sergiacomi; Luca Pugliese; Francesca Ricci; Roberto Floris; Armando Fusco
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region.

Authors:  Rossella Di Bidino; Paola Rogliani; Alfredo Sebastiani; Alberto Ricci; Francesco Varone; Giacomo Sgalla; Bruno Iovene; Teresa Bruni; Maria Chiara Flore; Michela D'Ascanio; Francesco Cavalli; Daniela Savi; Loreta Di Michele; Americo Cicchetti; Luca Richeldi
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 4.  The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.

Authors:  Giulia Maria Stella; Vito D'Agnano; Davide Piloni; Laura Saracino; Sara Lettieri; Francesca Mariani; Andrea Lancia; Chandra Bortolotto; Pietro Rinaldi; Francesco Falanga; Cristiano Primiceri; Angelo Guido Corsico; Andrea Bianco
Journal:  Transl Lung Cancer Res       Date:  2022-03

5.  Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.

Authors:  Fernando Pedraza-Serrano; Ana López de Andrés; Rodrigo Jiménez-García; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; Gema Sánchez-Muñoz; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  BMJ Open       Date:  2017-02-13       Impact factor: 2.692

6.  Pathway‑based detection of idiopathic pulmonary fibrosis at an early stage.

Authors:  Guojun Zhou; Fangxia Zhang; Yufang Liu; Bin Sun
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

7.  Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study.

Authors:  Vincent Cottin; Aurélie Schmidt; Laura Catella; Fanny Porte; Céline Fernandez-Montoya; Katell Le Lay; Stève Bénard
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

8.  Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.

Authors:  Jaana Kaunisto; K Kelloniemi; E Sutinen; U Hodgson; A Piilonen; R Kaarteenaho; R Mäkitaro; M Purokivi; E Lappi-Blanco; S Saarelainen; H Kankaanranta; A Mursu; M Kanervisto; E-R Salomaa; M Myllärniemi
Journal:  BMC Pulm Med       Date:  2015-08-19       Impact factor: 3.317

9.  Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.

Authors:  Sergio Harari; Fabiana Madotto; Antonella Caminati; Sara Conti; Giancarlo Cesana
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 10.  Global incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Toby M Maher; Elisabeth Bendstrup; Louis Dron; Jonathan Langley; Gerald Smith; Javaria Mona Khalid; Haridarshan Patel; Michael Kreuter
Journal:  Respir Res       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.